454 related articles for article (PubMed ID: 15792682)
21. Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5'-diphosphate receptor stimulation and cyclic calcium signaling.
Goto S; Tamura N; Ishida H; Ruggeri ZM
J Am Coll Cardiol; 2006 Jan; 47(1):155-62. PubMed ID: 16386680
[TBL] [Abstract][Full Text] [Related]
22. Recent development of peptides from glycoproteins IIb (alphaIIb) and IIIa (beta3) that inhibit platelet fibrinogen binding.
Chiang TM
Curr Med Chem Cardiovasc Hematol Agents; 2005 Apr; 3(2):99-103. PubMed ID: 15853697
[TBL] [Abstract][Full Text] [Related]
23. Effect of a synthetic peptide corresponding to residues 313 to 320 of the alphaIIb subunit of the human platelet integrin alphaIIbbeta3 on carotid artery thrombosis in rabbits.
Papamichael ND; Stathopoulou EM; Roussa VD; Tsironis LD; Kotsia AP; Stanica RM; Moussis V; Tsikaris V; Katsouras CS; Tselepis AD; Michalis LK
J Pharmacol Exp Ther; 2009 May; 329(2):634-40. PubMed ID: 19244095
[TBL] [Abstract][Full Text] [Related]
24. Platelet activation as a potential mechanism of GP IIb/IIIa inhibitor-induced thrombocytopenia.
Peter K; Straub A; Kohler B; Volkmann M; Schwarz M; Kübler W; Bode C
Am J Cardiol; 1999 Sep; 84(5):519-24. PubMed ID: 10482148
[TBL] [Abstract][Full Text] [Related]
25. Clues for understanding the structure and function of a prototypic human integrin: the platelet glycoprotein IIb/IIIa complex.
Calvete JJ
Thromb Haemost; 1994 Jul; 72(1):1-15. PubMed ID: 7974356
[TBL] [Abstract][Full Text] [Related]
26. The state of platelets preserved in extracorporeal circulation with a glycoprotein IIb/IIIa inhibitor.
Kondo N; Wakayama F; Suzuki Y; Fukui K; Takaya S; Fukuda I
Thromb Res; 2004; 113(5):303-10. PubMed ID: 15183042
[TBL] [Abstract][Full Text] [Related]
27. Role of glycoprotein IIb-IIIa (alpha IIb beta 3-integrin) in stimulation of secretion from platelet granules.
Naimushin YA; Mazurov AV
Biochemistry (Mosc); 2003 Feb; 68(2):209-16. PubMed ID: 12693968
[TBL] [Abstract][Full Text] [Related]
28. Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation.
Straub A; Wendel HP; Dietz K; Schiebold D; Peter K; Schoenwaelder SM; Ziemer G
Thromb Haemost; 2008 Mar; 99(3):609-15. PubMed ID: 18327411
[TBL] [Abstract][Full Text] [Related]
29. Paradoxical inhibition of fibrinogen binding and potentiation of alpha-granule release by specific types of inhibitors of glycoprotein IIb-IIIa.
Schneider DJ; Taatjes DJ; Sobel BE
Cardiovasc Res; 2000 Jan; 45(2):437-46. PubMed ID: 10728364
[TBL] [Abstract][Full Text] [Related]
30. Distinct but critical roles for integrin alphaIIbbeta3 in platelet lamellipodia formation on fibrinogen, collagen-related peptide and thrombin.
Thornber K; McCarty OJ; Watson SP; Pears CJ
FEBS J; 2006 Nov; 273(22):5032-43. PubMed ID: 17032352
[TBL] [Abstract][Full Text] [Related]
31. Interaction of wheat germ agglutinin and concanavalin A with platelets. Stimulation of platelet functional reactions and binding with membrane glycoproteins.
Smirnova IV; Khaspekova SG; Ignatov VV; Mazurov AV
Biochemistry (Mosc); 1998 Jun; 63(6):710-8. PubMed ID: 9668212
[TBL] [Abstract][Full Text] [Related]
32. Effects of roxifiban on platelet aggregation and major receptor expression in patients with coronary artery disease for the Roxifiban Oral Compound Kinetics Evaluation Trial-I (ROCKET-I Platelet Substudy).
Serebruany VL; Malinin AI; O'connor CM; Gurbel PA;
Am Heart J; 2003 Jul; 146(1):91-8. PubMed ID: 12851613
[TBL] [Abstract][Full Text] [Related]
33. Immunolocalization of platelet glycoprotein IIb/IIIa and P-selectin, and neutrophil-platelet interaction in human coronary unstable plaques.
Ikuta T; Naruko T; Ikura Y; Ohsawa M; Fukushima H; Shirai N; Itoh A; Haze K; Ehara S; Sasaki Y; Shibata T; Suehiro S; Ueda M
Int J Mol Med; 2005 Apr; 15(4):573-7. PubMed ID: 15754016
[TBL] [Abstract][Full Text] [Related]
34. Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors.
Peter K; Schwarz M; Ylänne J; Kohler B; Moser M; Nordt T; Salbach P; Kübler W; Bode C
Blood; 1998 Nov; 92(9):3240-9. PubMed ID: 9787160
[TBL] [Abstract][Full Text] [Related]
35. Principal role of glycoprotein VI in alpha2beta1 and alphaIIbbeta3 activation during collagen-induced thrombus formation.
Lecut C; Schoolmeester A; Kuijpers MJ; Broers JL; van Zandvoort MA; Vanhoorelbeke K; Deckmyn H; Jandrot-Perrus M; Heemskerk JW
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1727-33. PubMed ID: 15231520
[TBL] [Abstract][Full Text] [Related]
36. MK-383 (tirofiban) induces a GPIIb/IIIa receptor conformation which differs from the resting and activated receptor.
Barlage S; Wimmer A; Pfeiffer A; Rothe G; Schmitz G
Platelets; 2002 May; 13(3):133-40. PubMed ID: 12180495
[TBL] [Abstract][Full Text] [Related]
37. Evidence for selective degradation of platelet GP IIb/IIIa complex after prolonged in vitro ventricular assist.
Serna DL; King BO; Huh J; Jalal R; Tran L; Chen JC
J Investig Med; 1998 Aug; 46(6):279-83. PubMed ID: 9737089
[TBL] [Abstract][Full Text] [Related]
38. Allicin and disulfiram enhance platelet integrin alphaIIbbeta3-fibrinogen binding.
Manaster Y; Shenkman B; Rosenberg N; Savion N
Thromb Res; 2009 Sep; 124(4):477-82. PubMed ID: 19632706
[TBL] [Abstract][Full Text] [Related]
39. The stratification of platelet reactivity and activation in patients with stable coronary artery disease on aspirin therapy.
Gurbel PA; Bliden KP
Thromb Res; 2003; 112(1-2):9-12. PubMed ID: 15013266
[TBL] [Abstract][Full Text] [Related]
40. [GP IIb/IIIa receptor antagonists--molecular and clinical aspects].
Francuz T
Postepy Hig Med Dosw; 2001; 55(3):419-32. PubMed ID: 11505641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
